Interesting that the wording on the Divoc website has changed since this morning. It originally said that approval in India had been achieved in record time. Now it says:
‘ DIVOC has applied for regulatory clearance in India. The Indian regulatory process has recently been amended and now requires successful performance evaluation by the Indian Council of Medical Research, which DIVOC is pursuing. The Company is optimistic that India registration could be obtained. ’
‘ Bringing this new test to India and getting it approved in record time has been excellent and we look forward to helping the test become fully integrated into the Indian market. ’
This ties in my post yesterday re Calculus that they are promoting the C19 test in their site. I too think they’ve finished.
I saw a lot of talk about GDR on Friday in another group I am in. The talk was promoting it in the run up to the interviews then some clearly pulled out after. Maybe it was simply traders that took us down on Friday as they weren’t happy with what they saw.
The linked-in link doesn’t work anymore as it seems to have gone from the site (old news) but encouraging promotion of the companies C19 test here on the Calculus website:
RE: BGF Investment Management Limited29 May 2020 21:34
It seems clear that despite the great potential here to move the SP up we need the II’s to finish selling. If it’s only Calculus now and the others are happy with their lots then hopefully not long to go now.
RE: BGF Investment Management Limited29 May 2020 21:31
The BGF update shows they have another 1,562,500 shares which sounds like the number they were applying for in the placing. Hopefully no more selling now from them.